Kalpit Patel
Stock Analyst at Wolfe Research
(4.42)
# 1,174
Out of 4,504 analysts
218
Total ratings
39.8%
Success rate
16.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Maintained: Buy | $340 | $298.70 | +13.83% | 4 | Jul 1, 2026 | |
| GMAB Genmab | Maintained: Buy | $32 | $29.00 | +10.34% | 2 | Jun 14, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $35 | $31.06 | +12.69% | 1 | Jun 8, 2026 | |
| CGON CG Oncology | Maintained: Hold | n/a | $75.24 | - | 2 | May 26, 2026 | |
| CTMX CytomX Therapeutics | Initiated Coverage: Buy | $6 | $3.76 | +59.57% | 1 | May 19, 2026 | |
| MIRM Mirum Pharmaceuticals | Initiated Coverage: Buy | $145 | $122.13 | +18.73% | 1 | May 19, 2026 | |
| TYRA Tyra Biosciences | Initiated Coverage: Hold | n/a | $32.75 | - | 1 | May 19, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $165 | $186.88 | -11.71% | 1 | May 6, 2026 | |
| CORT Corcept Therapeutics | Upgraded: Hold | n/a | $91.88 | - | 2 | Mar 26, 2026 | |
| KRYS Krystal Biotech | Initiated Coverage: Hold | n/a | $365.81 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $11.91 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $5.53 | +189.33% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $33.69 | +9.82% | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.39 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $119.35 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $19.74 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $28 | $9.68 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $14 | $4.41 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $6.91 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $24 | $42.55 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $29 | $23.61 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $1.50 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $5.95 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $4.41 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.52 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $2.00 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $0.7739 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $11.05 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $97.60 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.33 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.66 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $6 | $0.0127 | n/a | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $43.92 | n/a | 6 | Nov 26, 2021 |
BeOne Medicines AG
Jul 1, 2026
Maintained: Buy
Price Target: $340
Current: $298.70
Upside: +13.83%
Genmab
Jun 14, 2026
Maintained: Buy
Price Target: $32
Current: $29.00
Upside: +10.34%
Tango Therapeutics
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $31.06
Upside: +12.69%
CG Oncology
May 26, 2026
Maintained: Hold
Price Target: n/a
Current: $75.24
Upside: -
CytomX Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $3.76
Upside: +59.57%
Mirum Pharmaceuticals
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $122.13
Upside: +18.73%
Tyra Biosciences
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $32.75
Upside: -
Revolution Medicines
May 6, 2026
Maintained: Buy
Price Target: $165
Current: $186.88
Upside: -11.71%
Corcept Therapeutics
Mar 26, 2026
Upgraded: Hold
Price Target: n/a
Current: $91.88
Upside: -
Krystal Biotech
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $365.81
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $11.91
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $5.53
Upside: +189.33%
Jul 21, 2025
Maintained: Buy
Price Target: $37
Current: $33.69
Upside: +9.82%
Jun 16, 2025
Maintained: Buy
Price Target: $5
Current: $1.39
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $119.35
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $19.74
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $85 → $28
Current: $9.68
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: $17 → $14
Current: $4.41
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $9
Current: $6.91
Upside: n/a
Mar 5, 2025
Maintained: Hold
Price Target: $20 → $24
Current: $42.55
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $36 → $29
Current: $23.61
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $1.50
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $5.95
Upside: n/a
Nov 18, 2024
Maintained: Hold
Price Target: $1 → $15
Current: $4.41
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.52
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $10 → $7
Current: $2.00
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $0.7739
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $7
Current: $11.05
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $97.60
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.33
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $1.66
Upside: n/a
Jun 7, 2022
Maintained: Buy
Price Target: $12 → $6
Current: $0.0127
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $43.92
Upside: n/a